Excitement is building for Corbus Pharmaceutical’s Phase 3 clinical trial testing the safety and effectiveness of their new drug lenabasum in dermatomyositis patients.
Continue Reading
Arimoclomol clinical trial for IBM
There is good news for IBM patients who want to participate in the arimoclomol clinical trial.
Continue Reading
You may qualify for a research study
Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE). People diagnosed with lupus can sometimes also develop myositis, an inflammation of the skeletal muscles that causes weakness and loss of strength. Lupus myositis often affects the muscles of your neck, pelvis, thighs, shoulders, and upper arms. The Paisley Study…
Continue Reading
If you have myositis and lupus, you may qualify for a research study
Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE).
Continue Reading
Clinical trial: Pfizer study of PF-06823859
Pfizer is currently seeking adults 18 to 80 years of age for a dermatomyositis clinical trial.
Continue Reading